Antimicrobial sensitivity patterns of cerebrospinal fluid (CSF) isolates in Namibia: Implications for empirical antibiotic treatment of meningitis

Journal of Pharmaceutical Policy and Practice

Volumn 6, Issue 1, 2013, Pages

  Mengistu, Assegid ^a   Gaeseb, Johannes ^a   Uaaka, Gottfried ^b   Ndjavera, Christophine ^b   Kambyambya, Kennedy ^a   Indongo, Lazarus ^a   Kalemeera, Francis ^c   Ntege, Christopher ^c   Mabirizi, David ^c   Joshi, Mohan P ^c   Sagwa, Evans ^c  

^a Ministry of Health and Social Services   (Namibia)

^b Namibia Institute of Pathology   (Namibia)

^c Management Sciences for Health   (Namibia)

Author keywords

Antimicrobial resistance; Celebrospinal fluid; Culture and sensitivity; Empiric therapy; Meningitis; Namibia

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFALOTIN; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; CLOXACILLIN; COTRIMOXAZOLE; ERYTHROMYCIN; FUSIDIC ACID; GENTAMICIN; IMIPENEM; MEROPENEM; OFLOXACIN; OXACILLIN; PENICILLIN DERIVATIVE; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; TETRACYCLINE; VANCOMYCIN;

ACINETOBACTER BAUMANNII; ACINETOBACTER JUNII; ACINETOBACTER LWOFFII; ADOLESCENT; ADULT; AEROMONAS HYDROPHILA; ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACILLUS; BACILLUS CEREUS; BACTERIAL MENINGITIS; BACTERIUM ISOLATION; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID CULTURE; CHILD; COLIFORM BACILLUS; CROSS-SECTIONAL STUDY; DESCRIPTIVE RESEARCH; DISEASE SEVERITY; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING KLEBSIELLA PNEUMONIAE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HAEMOPHILUS INFLUENZAE; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; KLEBSIELLA; KLEBSIELLA OXYTOCA; KLEBSIELLA OZAENAE; KLEBSIELLA PNEUMONIAE; KOCURIA VARIANS; LISTERIA MONOCYGENES; MICROCOCCUS; MORAXELLA; MORGANELLA MORGANII; NAMIBIA; NEISSERIA MENINGITIDIS; NEWBORN; NONHUMAN; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS PAUCIMOBILIS; SALMONELLA; SALMONELLA OMNIVALENT POSITIVE; SERRATIA LIQUIFACIENS; SERRATIA MARCESCENS; SPHINGOMONAS PAUCIMOBILIS; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS CAPITIS; STAPHYLOCOCCUS EPIDERMIDES; STAPHYLOCOCCUS HAEMOLYTICUS; STAPHYLOCOCCUS HOMINIS; STAPHYLOCOCCUS SAPROPHYTICUS; STAPHYLOCOCCUS SIMULANS; STREPTOCOCCUS; STREPTOCOCCUS AGALACTEAE; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS GROUP A; STREPTOCOCCUS PNEUMONIAE; YERSINIA PESTIS;

EID: 84904735685     PISSN: None     EISSN: 20523211     Source Type: Journal    
DOI: 10.1186/2052-3211-6-4     Document Type: Article

References (22)

1. Tunkel RA, Scheld WM. Pathogenesis and pathophysiology of bacterial meningitis. Clin Micro Rev 1993, 6:118-136. 358273, 8472245.
2. Aronin SI. Bacterial meningitis: principles and practical aspects of therapy. Curr Infect Dis Rep 2000, 2:337-344. 10.1007/s11908-000-0013-0, 11095875.
3. O'Donnell EP, Hurt KM, Scheetz MH, Postelnick MJ, Scarsi KK. Empiric antibiotic selection for infectious emergencies: bacterial pneumonia, meningitis and sepsis. Drugs Today (Barc) 2009, 45(5):379-393.
4. Brouwer MC, Tunkel AR, Van de Beek D. Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis. Clin Microbiol Rev 2010, 23(3):467-492. 2901656, 20610819.
5. Geiseler PJ, Nelson KE, Levin S, Reddi KT, Moses VK. Community-Acquired Purulent meningitis: a review of 1,316 cases during the Antibiotic Era, 1954-1976. Rev Infect Dis 1980, 2(5):725-745. Sep-Oct, 10.1093/clinids/2.5.725, 6763303.
6. Schuchat A, Robinson K, Wenger JD, Harrison LH, Farley M, Reingold AL, et al. Bacterial meningitis in the United States in 1995. Active Surveillance Team. N Engl J Med 1997, 337:970-976. 10.1056/NEJM199710023371404, 9395430.
7. Davison KL, Ramsay ME. The epidemiology of acute meningitis in children in England and Wales. Arch Dis Child 2003, 88:662-664. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1719594/pdf/v088p00662.pdf, 10.1136/adc.88.8.662, 1719594, 12876156.
8. Jones ME, Draghi DC, Karlowsky JA, Sahm DF, Bradley JS. Prevalence of antimicrobial resistance in bacteria isolated from central nervous system specimens as reported by U.S. hospital laboratories from 2000 to 2002. Ann Clin Microbiol Antimicrob 2004, 3:3. 10.1186/1476-0711-3-3, 406416, 15043754.
9. Grundmanna H, Klugman KP, Walsh T, Ramon-Pardoe P, Sigauquef B, Khanh W, et al. A framework for global surveillance of antibiotic resistance. Drug Resist Up 2011, 1479-1487.
10. Kim KS. Treatment strategies for central nervous system infections. Expert Opin Pharmacother 2009, 10:1307-1317. 10.1517/14656560902953720, 19445565.
11. Wubbel L, McCracken GH. Management of bacterial meningitis. Pediatr Rev 1998, 193:78-84.
12. Kaplan SL. Clinical presentations, diagnosis, and prognostic factors of bacterial meningitis. Infect Dis Clin North Am 1999, 13:579-594. 10.1016/S0891-5520(05)70095-7, 10470556.
13. Sutinen J, Sombrero L, Paladin FJ, Julkunen I, Leinikki P, Hernandez E, et al. Etiology of central nervous system infections in the Philippines and the role of serum C-reactive protein in excluding acute bacterial meningitis. Int J Infect Dis 1998-1999, 3(2):88-93.
14. Taylor WR, Nguyen K, Nguye D, Nguye H, Horby P, Nguyen HL, et al. The spectrum of central nervous system infections in an Adult Referral Hospital in Hanoi, Vietnam. PLoS One 2012, 7(8):e42099. August, 10.1371/journal.pone.0042099, 3431395, 22952590.
15. Huttunen P, Lappalainen M, Salo E, Lönnqvist T, Jokela P, Hyypiä T, Peltola H. Differential diagnosis of acute Central Nervous System Infections in children using Modern Microbiological methods. Acta Paediatr 2009, 98(8):1300-1306. 10.1111/j.1651-2227.2009.01336.x, 19432824.
16. Tunkel AR, Hartman BJ, Kaplan SL, Kaufman BA, Roos KL, Scheld WM, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 2004, 39(9):1267-1284. 10.1086/425368, 15494903.
17. Fauci AS, Lane HC. HIV neurology. Harrison's Neurology in Clinical Medicine 2010, 493-506. New York, NY: McGraw-Hill Professional, Hauser SL, Josephson SA, 2.
18. Cunha BA. Effective antibiotic-resistance control strategies. Lancet 2001, 357(9265):1307-1308. 10.1016/S0140-6736(00)04527-X, 11343730.
19. Song JH, Jung SI, Ko KS, Kim NY, Son JS, Chang HH, et al. High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP study). Antimicrob Agents Chemother 2004, 48(6):2101-2107. 10.1128/AAC.48.6.2101-2107.2004, 415617, 15155207.
20. Centers for Disease Control and Prevention Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Streptococcus pneumoniae, 2010 2012, http:/www.cdc.gov/abcs/reports-findings/survreports/spneu08.pdf, Centers for Disease Control and Prevention.
21. Sarojamma V, Ramakrishna V. Prevalence of ESBL-Producing Klebsiella pneumoniae Isolates in Tertiary Care Hospital International Scholarly Research Network ISRN Microbiology Volume 2011, Article ID 318348, 5 pages.
22. Sidjabat H, Nimmo GR, Walsh TR, Binotto E, Htin A, Hayashi Y, et al. Carbapenem resistance in Klebsiella pneumoniae due to the New Delhi Metallo-ß-lactamase. Clin Infect Dis 2011, 52(4):481-484. 10.1093/cid/ciq178, 3106237, 21258100.